Send mail to Author

Randomized trial of the efficacy and safety of Berotralstat (BCX7353) as an oral prophylactic therapy for hereditary angioedema: results of APeX-2 ihrough 48 weeks (Part 2) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __    ______   _    _      ___      ______   _    _   
 | |/ //  /_   _// | || | ||   / _ \\   /_   _// | || | || 
 | ' //    -| ||-  | || | ||  | / \ ||    | ||   | || | || 
 | . \\    _| ||_  | \\_/ ||  | \_/ ||   _| ||   | \\_/ || 
 |_|\_\\  /_____//  \____//    \___//   /__//     \____//  
 `-` --`  `-----`    `---`     `---`    `--`       `---`   
                                                           
 


Back to frontdoor view